Current Liabilities
Accrued Manufacturing Costs
International Business Machines Accrued Manufacturing Costs decreased by 4.2% to $3.94B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.9%, from $3.65B to $3.94B. Over 5 years (FY 2020 to FY 2025), Accrued Manufacturing Costs shows an upward trend with a 6.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2015
Last reportedQ1 2026Apr 23, 2026
Metric ID:
accrued_manufacturing_costsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.85B | $3.78B | $3.20B | $2.94B | $3.33B | $3.37B | $3.48B | $2.77B | $3.19B | $3.26B | $3.50B | $3.19B | $3.13B | $3.25B | $3.61B | $3.65B | $3.35B | $3.51B | $4.11B | $3.94B |
| QoQ Change | — | -1.7% | -15.2% | -8.3% | +13.3% | +1.3% | +3.3% | -20.4% | +14.9% | +2.3% | +7.5% | -8.9% | -2.0% | +4.0% | +10.9% | +1.3% | -8.2% | +4.6% | +17.3% | -4.2% |
| YoY Change | — | — | — | — | -13.5% | -10.9% | +8.6% | -5.6% | -4.3% | -3.3% | +0.6% | +15.1% | -1.9% | -0.2% | +3.0% | +14.5% | +7.3% | +7.9% | +14.1% | +7.9% |
Range$2.77B – $4.11B
CAGR+0.5%
Avg YoY Growth+2.5%
Median YoY Growth+1.8%
Accrued Manufacturing Costs at Other Companies
Frequently Asked Questions
- What is International Business Machines's accrued manufacturing costs?
- International Business Machines (IBM) reported accrued manufacturing costs of $3.94B in Q1 2026.
- How has International Business Machines's accrued manufacturing costs changed year-over-year?
- International Business Machines's accrued manufacturing costs increased by 7.9% year-over-year, from $3.65B to $3.94B.
- What is the long-term trend for International Business Machines's accrued manufacturing costs?
- Over 5 years (2020 to 2025), International Business Machines's accrued manufacturing costs has grown at a 6.1% compound annual growth rate (CAGR), from $3.06B to $4.11B.